UPenn Gene Therapy Program Joining Discovery Labs Ecosystem

Discovery Labs suburban Philadelphia campus gained a new tenant, the University of Pennsylvania Gene Therapy Program (GTP), which focuses on the development of AAV-based gene therapies for rare and orphan genetic diseases with high unmet needs.

The Gene Therapy Program, helmed by Dr. James M. Wilson, will become an anchor tenant for the Discovery Labs’ emerging seven-million-square-foot life sciences cluster in Cellicon Valley, the moniker given to the Philadelphia region due to the significant presence of cell and gene therapy companies.

Read full story